XML 23 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Preferred Stock
Common Stock
Add'l Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Unearned ESOP
Treasury Stock
Noncontrolling Interests
Beginning balance at Dec. 31, 2015 $ 26,183 $ 4,000 $ 3,107 $ 4,936 $ 28,425 $ (8,667) $ (272) $ (6,155) $ 809
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income available for The Dow Chemical Company common stockholder 3,978       3,978        
Other comprehensive Income (loss) (1,155)         (1,155)      
Dividends to stockholders (2,037)       (2,037)        
Common stock issued/sold 1,115     398       717  
Stock-based compensation and allocation of ESOP shares (325)     (376)     51    
ESOP shares acquired (18)           (18)    
Impact of noncontrolling interests 433               433
Treasury stock purchases (916)             (916)  
Preferred stock converted to common stock   (4,000)   695       4,695  
Other (29)     (1) (28)        
Ending balance at Dec. 31, 2016 27,229 0 3,107 4,262 30,338 (9,822) (239) (1,659) 1,242
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income available for The Dow Chemical Company common stockholder 466       466        
Other comprehensive Income (loss) 1,231         1,231      
Dividends to stockholders (1,673)       (1,673)        
Dividends to parent (1,056)       (1,056)        
Common stock issued/sold 1,147     423       724  
Issuance of parent company stock 66     66          
Stock-based compensation and allocation of ESOP shares (318)     (368)     50    
Impact of noncontrolling interests (56)               (56)
Merger impact 0   3,107 2,172       935  
Other (27)     (2) (25)        
Ending balance at Dec. 31, 2017 27,009 0 0 6,553 28,050 (8,591) (189) 0 1,186
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income available for The Dow Chemical Company common stockholder 4,499       4,499        
Other comprehensive Income (loss) (257)         (257)      
Dividends to parent (3,711)       (3,711)        
Issuance of parent company stock 112     112          
Stock-based compensation and allocation of ESOP shares 432     377     55    
Impact of noncontrolling interests (48)               (48)
Other (19)     0 (19)        
Ending balance at Dec. 31, 2018 $ 27,969 $ 0 $ 0 $ 7,042 $ 29,808 $ (9,885) $ (134) $ 0 $ 1,138